Read More

The condition, which affects around 300,000 people in the UK, is caused by damage to blood vessels, nerves, muscles and joints of the hand, wrist and arm from prolonged use of power tools.

Reactec said the latest funding round was led by Archangel with co-funding from the Scottish Investment Bank – the investment arm of Scottish Enterprise – as well as £122,000 from the Reactec board, management and staff.

The Edinburgh University spin-out launched its wearable HAVwear device last year, which provides constant vibration monitoring and automated reporting of any potential exposure to risk.

The company said HAVwear shipped 10,000 units in its first year, resulting in the company recording its first £1 million sales quarter.

Last September Reactec secured a new £900,000 loan deal with Clydesdale Bank to target industries outside its core construction base, both in the UK and internationally.

Read More

Reactec said the money raised in the latest follow-on funding round will help to build on growth achieved since the HAVwear release, supporting recruitment of four additional sales and engineering staff, taking Reactec’s headcount to 27, and “enabling international expansion and further research and development”.

Reactec chief executive Jacqui McLaughlin said: “HAVwear has achieved significant momentum since we launched it last year as the world’s first wearable vibration monitoring device, making monitoring of workers’ exposure to dangerous vibrations that cause HAVS more meaningful than ever before.

Reactec chief executive Jacqui McLaughlin: “HAVwear has achieved significant momentum since we launched it last year''

“I am thrilled that so many of our own people have chosen to invest their own cash in Reactec’s future, alongside Archangels and Scottish Investment Bank.

“This will help us to grow the business internationally and undertake further R&D.”

Read More

Sarah Hardy, chief investment officer at Archangels, said: “Reactec’s HAVwear product meets a clear customer need in protecting users from the debilitating effects of HAVS and we look forward to seeing this product increasing its impact in this important area.”

Scottish Investment Bank director Kerry Sharpe said Reactec is a “fine example” of an ambitious, fast-growing Scottish company developing a “market-leading product”.

She added: “It’s great to know that this funding will allow the company to expand its reach, target new geographies and create new employment in Edinburgh and we look forward to working with Reactec to help it to build on the commercial success it has already achieved.”